Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

RSS icon
Thumbnail

Current models overestimate CVD risk of 11.8M US adults

Updating the 2013 pooled cohort equations (PCEs) with more recent patient populations and new statistical methods results in approximately 11.8 million U.S. adults migrating to a lower-risk category, potentially affecting which therapies they would be indicated for to combat atherosclerosis.

Thumbnail

Green tea component may prevent heart attack, stroke

A compound found in green tea can break up the plaque that causes atherosclerosis, according to research published May 31 in the Journal of Biological Chemistry.

Getinge announces results from SEMPER FI pilot study of intra-aortic balloon pump showing numerical trend toward reduced mortality in patients with extensive myocardial infarction and persistent ischemia

WAYNE, N.J., May 25, 2018 — Getinge, a leading global provider of innovative medical technology, today announced results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia Following IABP Implantation (SEMPER FI) pilot study.

Thumbnail

Study links marijuana to increased death risk among young MI sufferers

About 10 percent of people who suffer a type 1 myocardial infarction (MI) at age 50 or younger use cocaine or marijuana, according to a new study, and these individuals showed double the risk of cardiovascular or all-cause death over extended follow-up.

Thumbnail

South Asians at increased risk for ASCVD than European ancestry counterparts

South Asians are more likely to die of atherosclerotic cardiovascular disease (ASCVD) than East Asians or people of European ancestry, according to a new scientific statement published in the American Heart Association’s journal Circulation on May 24.

Thumbnail

Depression screening crucial for patients with CAD to control mortality, morbidity

New research from Florida State University suggests depression screening in patients with coronary artery disease (CAD) is especially crucial, because those individuals tend to have higher rates of morbidity and mortality.

Thumbnail

Experts: Inflammation key to atherosclerosis—but more drug testing needed

Therapies targeting cholesterol and inflammation have both shown the ability to reduce cardiovascular events among patients with atherosclerosis, but more evidence is needed before anti-inflammatory drugs gain widespread use similar to statins, according to a consensus statement published May 14 in the European Journal of Preventive Cardiology.

Thumbnail

Industry leaders recommend collaboration with OB/GYNs for heart health

Annual well woman exams, traditionally performed by an OB/GYN, provide a “golden opportunity” for women to get their heart health evaluated, according to a new joint advisory issued by the head officials of the American Heart Association (AHA) and the American College of Obstetricians and Gynecologists (ACOG).

Displaying 545 - 552 of 665

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.